Treatment Outcomes of Durvalumab Combination Therapy in Patients with Biliary Tract Cancer.

20260 citationsJournal Article

Authors

GCD therapy demonstrated efficacy and safety similar to those observed in the TOPAZ-1 trial.

Good health and well-being

Published in: PubMed

Volume 51, Issue 1, pp. 36-39

Field-Weighted Citation Impact: 0.00